Krensavage Asset Management, LLC
NEW YORK, NY · CIK 1609251 · 13F filing filed 2026-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyNew York, NY
$263.2m
reported value
+2.9% vs Q1 2026
18positions
89.4%in top 10
0 new
4 added
2 reduced
2 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ENANTA PHARMACEUTICALS INC ENTA | $41.8m15.88% | Unchanged |
| JAZZ PHARMACEUTICALS PLC JAZZ | $40.4m15.36% | Unchanged |
| UNITED THERAPEUTICS CORP DEL UTHR | $37.5m14.26% | Reduced -15.0k |
| BIOMARIN PHARMACEUTICAL INC BMRN | $30.0m11.41% | Unchanged |
| EXELIXIS INC EXEL | $20.2m7.66% | Reduced -45.0k |
| ABBOTT LABS ABT | $18.1m6.89% | Added +195.0k |
| SANOFI SNY | $13.8m5.25% | Unchanged |
| SUPERNUS PHARMACEUTICALS INC SUPN | $13.1m4.96% | Unchanged |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $13.1m4.96% | Unchanged |
| VANDA PHARMACEUTICALS INC VNDA | $7.2m2.74% | Unchanged |
| BIONTECH SE BNTX | $5.5m2.10% | Unchanged |
| GSK PLC GSK | $5.1m1.93% | Unchanged |
| BIOGEN INC BIIB | $4.3m1.64% | Unchanged |
| REGENERON PHARMACEUTICALS REGN | $3.7m1.42% | Added +2.0k |
| EMBECTA CORP EMBC | $3.7m1.41% | Added +400.0k |
| ARDELYX INC ARDX | $2.7m1.04% | Added +34.5k |
| INMODE LTD INMD | $1.8m0.67% | Unchanged |
| EVOLUS INC EOLS | $1.1m0.42% | Unchanged |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| INDIVIOR PHARMACEUTICALS INC INDV | $10.3m339.5k shares |
| ALKERMES PLC ALKS | $3.8m107.8k shares |